GlobeNewswire by notified

PGS ASA: Implementation of 2023 Employee Long-term Incentive Plan

Share

May 22, 2023, Oslo, Norway: PGS (or the "Company") announces that the 2023 long term incentive plan, as approved by the Annual General Meeting on April 26, 2023, has now been implemented by allocating 4 639 000 Performance based Restricted Stock Units ("PRSUs").

The awards are based on amongst other considerations the position in the Company and a review on the individual participant's performance prior to award. Any PRSU awarded will, subject to the participant's continued employment with the Company (or a subsidiary), be settled three years after grant. The complete terms and conditions of the award are described in the calling notice for the 2023 Annual General Meeting.

Delivery of shares will take place from the Company's pool of treasury shares or, if an insufficient number of treasury shares exist, it will be settled by cash payment of an equivalent value.

The purpose of the long-term incentive plan is to further the interests of PGS, its subsidiaries and its shareholders to employees who can contribute materially to the success and profitability of PGS. Such awards will recognize and reward performance and individual contributions and give participants in the plan an interest in the Company parallel to that of the shareholders, thus enhancing the proprietary and personal interest in PGS' continued success and progress.

The Board of Directors has allocated PRSUs according to the plan to the following primary insiders in PGS:

Rune Olav Pedersen, President & CEO, has been awarded 329 000 PRSUs in the Company. Following the award, Pedersen holds 644 365 shares in PGS and 1 386 000 PRSUs.

Gottfred Langseth, Executive Vice President & CFO, has been awarded 140 000 PRSUs in the Company. Following the award, Langseth holds 1 268 297 shares in PGS and 586 000 PRSUs.

Nathan Oliver, Executive Vice President Sales & Services, has been awarded 140 000 PRSUs in the Company. Following the award, Oliver holds 15 000 shares in PGS and 586 000 PRSUs.

Robert J. Adams, Executive Vice President Operations, has been awarded 140 000 PRSUs in the Company. Following the award, Adams holds 16 126 shares in PGS and 586 000 PRSUs.

Berit Osnes, Executive Vice President New Energy, has been awarded 140 000 PRSUs in the Company. Following the award, Osnes holds 54 377 shares in PGS, 455 000 PRSUs.

Erik Ewig, Senior Vice President Technology & Digitalization, has been awarded 140 000 PRSUs in the Company. Following the award, Ewig holds 7 391 shares in PGS and 420 000 PRSUs 

Lars Ragnar Mysen, General Counsel, has been awarded 50 000 PRSUs in the Company. Following the award, Mysen holds 202 306 shares in PGS and 213 000 PRSUs.

Kristin Omreng, Senior Vice President Global HR, has been awarded 50 000 PRSUs in the Company. Following the award, Omreng holds 20 000 shares in PGS and 213 000 PRSUs.

Kai Reith, Senior Vice President Corporate Development, has been awarded 50 000 PRSUs in the Company. Following the award, Reith holds 90 647 shares in PGS and 213 000 PRSUs.

Bård Stenberg, Vice President IR & Corporate Communications, has been awarded 50 000 PRSUs in the Company. Following the award, Stenberg holds 26 000 shares in PGS and 210 000 PRSUs.

Anette Valbø, employee elected Board Member and Bidding Manager, has been awarded 10 500 PRSUs in the Company. Following the award, Valbø holds 13 354 shares in PGS and 44 000 PRSUs.

Eivind Vesterås, employee elected Board Member and Special Projects Manager, has been awarded 10 500 PRSUs in the Company. Following the award, Vesterås holds 158 500 shares in PGS and 38 500 PRSUs.

Carine Roalkvam, employee elected Board Member and Regional Geophysical Advisor & Geophysical Support Manager, has been awarded 15 000 PRSUs in the Company. Following the award, Roalkvam holds 970 shares in PGS and 63 000 PRSUs.

Gunhild Myhr, employee elected alternate Board Member and Business Development Manager, has been awarded 30 000 PRSUs in the Company. Following the award, Myhr holds 1 940 shares in PGS and 79 500 PRSUs.

Merethe Bryn, employee elected alternate Board Member and VP Global Tax, has been awarded 30 000 PRSUs in the Company. Following the award, Bryn holds 12 427 shares in PGS and 134 000 PRSUs 

Christopher Watts, employee elected alternate Board Member and VP Sales & Services, has been awarded 23 000 PRSUs in the Company. Following the award, Watts holds 0 shares in PGS and 97 000 PRSUs.

Further details on remuneration of management are described in PGS’ 2022 annual report.

This information is subject to disclosure requirements set out in the Market Abuse Regulation EU 596/2014 Article 19 and the Norwegian Securities Trading Act Section 5-12.


Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Brookfield Reinsurance Completes Acquisition of AEL2.5.2024 22:10:00 CEST | Press release

BROOKFIELD, NEWS, May 02, 2024 (GLOBE NEWSWIRE) -- Brookfield Reinsurance (NYSE, TSX: BNRE, BNRE.A) and American Equity Investment Life Holding Company (NYSE: AEL) (“AEL”) today announced the completion of Brookfield Reinsurance’s acquisition of AEL in a cash and stock transaction valued at $56.50 per AEL share. AEL’s leading fixed annuity business bolsters Brookfield Reinsurance’s expanding insurance operations and increases its insurance assets under management to over $100 billion. Jon Bayer, Managing Partner at Brookfield Reinsurance said, “We are excited to welcome AEL to our organization as we continue to grow, diversify and scale our retirement services capabilities. AEL’s strong franchise and track record of serving policyholders and distribution partners, coupled with the scale of our existing platform and offerings, will position us well for the next phase of growth.” Brookfield Reinsurance expects to maintain AEL’s headquarters in Des Moines, Iowa, and its growth in the fixe

Fortinet Reports First Quarter 2024 Financial Results2.5.2024 22:05:43 CEST | Press release

First Quarter 2024 Highlights Total revenue of $1.35 billion, up 7% year over yearService revenue of $944 million, up 24% year over yearGAAP operating margin of 23.7%Non-GAAP operating margin of 28.5%1Cash flow from operations of $830 millionFree cash flow of $609 million1 SUNNYVALE, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- Fortinet® (Nasdaq: FTNT), a global cybersecurity leader driving the convergence of networking and security, today announced financial results for the first quarter ended March 31, 2024. “We are diligently executing on our strategy announced six months ago to leverage our scale, go-to-market capabilities, customer-first focus, and engineering expertise to capitalize on the fast-growing Unified SASE and Security Operations markets while continuing to gain market share in Secure Networking,” said Ken Xie, Founder, Chairman and Chief Executive Officer of Fortinet. “We believe our Unified SASE offering is the most comprehensive in the industry and we are well-positioned

Zymeworks Provides Corporate Update and Reports First Quarter 2024 Financial Results2.5.2024 22:05:00 CEST | Press release

Reported $420.5 million in cash resources as of March 31, 2024, which when combined with certain anticipated regulatory milestone payments provides projected cash runway into 2H 2027Completion of rolling biologics license application (BLA) filing with the U.S. Food and Drug Administration (FDA) for zanidatamab as second-line treatment for biliary tract cancers (BTC) in the United States (U.S.) by our partner, Jazz PharmaceuticalsExpected initiation of a Phase 3 clinical trial for zanidatamab in the second half of 2024, for breast cancer patients who have progressed on trastuzumab deruxtecan (T-DXd), by our partner, Jazz Pharmaceuticals Two planned investigational new drug (IND) and foreign equivalent submissions in 2024 for ZW191 and ZW171Acceptance of an abstract for zanidatamab in BTC at the American Society of Clinical Oncology (ASCO) annual meeting submitted by our partner, Jazz PharmaceuticalsPresentation of five abstracts at the American Association for Cancer Research (AACR) ann

Willscot Mobile Mini Reports First Quarter 2024 Results2.5.2024 22:01:00 CEST | Press release

Solid Modular and Value-Added Products Demand Support Full Year 2024 Outlook PHOENIX, May 02, 2024 (GLOBE NEWSWIRE) -- WillScot Mobile Mini Holdings Corp. (“WillScot Mobile Mini” or the “Company”) (Nasdaq: WSC), a leader in innovative temporary flexible space solutions, today announced first quarter 2024 results and provided an update on operations and the current market environment, including the following highlights: Q1 2024 Revenue increased 4% to $587 million and Income from continuing operations was $56 million. Income from operations included approximately $15 million of integration and transaction-related expenses. Adjusted EBITDA was flat year-over-year at $248 million.Generated Net cash provided by operating activities of $209 million and Free Cash Flow of $144 million, both up 40% year-over-year, with Free Cash Flow Margin of 24.5%, which increased by 660 basis points.Maintained leverage sequentially at 3.3x Net Debt to Adjusted EBITDA as of March 31, 2024, inside our target

Galapagos reports first quarter 2024 financial results2.5.2024 22:01:00 CEST | Press release

Advanced potentially best-in-class cell therapy and small molecule R&D pipeline comprising four clinical assets and >15 discovery programs in oncology and immunologyExecuted agreements with BridGene Biosciences and Thermo Fisher Scientific, and investment in Frontier MedicinesTransferred Jyseleca® business to Alfasigma S.p.A., freeing up resources to invest in growth areasGroup net revenues in the first quarter of €100 millionCash and current financial investments of €3.6 billion on 31 March 2024Reconfirmed 2024 cash burni guidance of €280 million to €320 million, not including potential business development opportunities Webcast presentationwith management on 3 May 2024,at 14:00 CET/8:00 am ET,www.glpg.com Mechelen, Belgium; 2 May 2024, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) today announced its first quarter 2024 financial results and provided a business update and outlook for the remainder of 2024. “We are moving forward with a renewed focus, a diff

HiddenA line styled icon from Orion Icon Library.Eye